Phase 2b trial assessing LTI-01 for the treatment of loculated pleural effusions (LPEs)
Latest Information Update: 16 Jan 2025
Price :
$35 *
At a glance
- Drugs LTI 01 (Primary)
- Indications Pleural effusion
- Focus Therapeutic Use
- 16 Jan 2025 New trial record
- 10 Jan 2025 According to Rein Therapeutics media release, Aileron Therapeutics announces rebranding to Rein Therapeutics